Phase2 Study of TS-141 in Child Patients With ADHD (Double-blind, Parallel Group Study)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080223189

Enrollment

200

Registered

2016-05-09

Start date

2016-05-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention-Deficit/Hyperactivity Disorder (ADHD)

Interventions

investigational material(s) Generic name etc : TS-141 INN of investigational material : - Therapeutic category code : 119 Other agents affecting central nervous system Dosage and Administration for In

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Child patients diagnosed with ADHD - Outpatients etc.

Exclusion criteria

Exclusion criteria: - Having other central nervous system disease etc.

Design outcomes

Primary

Measure	Time frame
efficacy efficacy(frequency of ADHD)	—

Secondary

Measure	Time frame
efficacy efficacy(degree of ADHD,QOL etc)	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026